Momar Ndao, Ph.D.
Tel: (514) 934-1934 ext. 44537
During the past few years increased awareness of parasitic infections has led to newly recognized parasites, emerging pathogens, and bioterrorism considerations; the fields of diagnostic medical parasitology, treatment and vaccines are undergoing dramatic change. My laboratory has interests in 1) diagnosis of parasitic diseases 2) the study of host-parasite interactions; 3) screening drugs to be used as therapies for protozoan parasitic disease; 4) developing vaccines to prevent parasitic diseases and 5) applying proteomic technology to discover biomarkers for infectious diseases.
Plourde M, Coelho A, Keynan Y, Larios OE, Ndao M, Ruest A, Roy G, Rubinstein E, Ouellette M.Genetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan. PLoS Negl Trop Dis. 2012 Jan;6(1):e1463. Epub 2012 Jan 17.
Sampasa-Kanyinga H, Lévesque B, Anassour-Laouan-Sidi E, Côté S, Serhir B, Ward BJ, Libman MD, Drebot MA, Ndao M, Dewailly E.Zoonotic Infections in Native Communities of James Bay, Canada. Vector Borne Zoonotic Dis. 2012 Jan 4. [Epub ahead of print]
Ndao M.Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry. Methods Mol Biol. 2012;818:67-79.